ophthalmologytimes10h
Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg
Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
ophthalmologyadvisor15h
In Diabetic Eye Disease, Loss to Follow-Up Linked With Race, Distance From Care
Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.